Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban

  • Schmitt, Joachim P.
  • Kamisago, Mitsuhiro
  • Asahi, Michio
  • Li, Guo Hua
  • Ahmad, Ferhaan
  • Mende, Ulrike
  • Kranias, Evangelia G.
  • MacLennan, David H.
  • Seidman, J. G.
  • Seidman, Christine E.
Science 299(5611):p 1410-1413, February 28, 2003.

Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars annually, remain poorly understood. Here we report that an inherited human dilated cardiomyopathy with refractory congestive heart failure is caused by a dominant Arg → Cys missense mutation at residue 9 (R9C) in phospholamban (PLN), a transmembrane phosphoprotein that inhibits the cardiac sarcoplasmic reticular Ca2+-adenosine triphosphatase (SERCA2a) pump. Transgenic PLNR9C mice recapitulated human heart failure with premature death. Cellular and biochemical studies revealed that, unlike wild-type PLN, PLNR9C did not directly inhibit SERCA2a. Rather, PLNR9C trapped protein kinase A (PKA), which blocked PKA-mediated phosphorylation of wild-type PLN and in turn delayed decay of calcium transients in myocytes. These results indicate that myocellular calcium dysregulation can initiate human heart failure-a finding that may lead to therapeutic opportunities.

Copyright © 2003 by the American Association for the Advancement of Science
View full text